Early research (Phase 1)Study completedNCT01842386
What this trial is testing
Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Who this might be right for
Pulmonary Alveolar Proteinosis (PAP)Severe Mucocutaneous Candidiasis
National Institute of Allergy and Infectious Diseases (NIAID) 7